NCT00401401View on ClinicalTrials.gov

Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Head and Neck CancerSquamous Cell Cancer
Interventions
DRUG

zalutumumab

Eight weekly infusions

DRUG

cisplatin

Infusions

PROCEDURE

Radiotherapy

Daily in the treatment period

Trial Locations (7)

97239

Oregon Health Sciences Center, Portland

Unknown

St-Luc University Hospital, Brussels

University Hospital Gasthuisberg, Leuven

Centre Georges-Francois Leclerc Hospital, Dijon

Hopital Bretonneau Clinique d'Oncologie et Radiothérapie, Tours

Nijmegen University Hospital, Nijmegen

Lund University Hospital, Lund

Sponsors

Lead Sponsor

Genmab
All Listed Sponsors
lead

Genmab

INDUSTRY

NCT00401401 - Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer | Biotech Hunter | Biotech Hunter